We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 749

$26.8 million settlement with Cardinal Health marks second-highest FTC disgorgement
  • McGuireWoods LLP
  • USA
  • May 18 2015

On April 20, 2015, the FTC announced its $26.8 million settlement with Cardinal Health, Inc. The FTC charged Cardinal Health with illegally


Animal compounding guidance (draft) for use of bulk drug substances released by FDA today
  • McGuireWoods LLP
  • USA
  • May 18 2015

On May 18, 2015, FDA released new draft guidance on animal drug compounding from bulk drug substances. While FDA's current statutory framework and


Carefirst suffers cyberattack, data breach of 1.1 million customers’ information
  • McGuireWoods LLP
  • USA
  • May 20 2015

Health insurer CareFirst BlueCross BlueShield disclosed today that hackers gained access to one of its databases, exposing personally identifiable


New FAQs regarding preventive services under healthcare reform
  • McGuireWoods LLP
  • USA
  • May 15 2015

This is the 49th in a series of WorkCite articles concerning the Patient Protection and Affordable Care Act and its companion statute, the Health


Weekly Washington healthcare update - May 04, 2015
  • McGuireWoods LLP
  • USA
  • May 7 2015

On April 29, bipartisan House Energy and Commerce Committee leadersChairman Upton, Oversight and Investigations Subcommittee Ranking Member DeGette


Otsuka files amended complaint and motion for tropi for Abilify, pointing to Congressional intent to argue broad exclusivity
  • McGuireWoods LLP
  • USA
  • May 15 2015

As discussed in our April 13, 2015 blog, Otsuka Pharmaceutical Co., Ltd. Otsuka Pharmaceutical Development and Commercialization, Inc., and Otsuka


Otsuka’s orphan drug exclusivity claims: FDA rips off the band-aid early
  • McGuireWoods LLP
  • USA
  • April 23 2015

On April 20, 2015, FDA filed a brief in Opposition to Plaintiff’s Motion for Temporary Restraining Order (“TRO”) or Preliminary Injunction (“PI”


Otsuka’s orphan drug exclusivity claims: FDA rips off the band-aid early
  • McGuireWoods LLP
  • USA
  • April 24 2015

Sometimes you need to get in front of the issue earlyOn April 20, 2015, FDA filed a brief in Opposition to Plaintiff’s Motion for Temporary


Weekly Washington healthcare update - May 11, 2015
  • McGuireWoods LLP
  • USA
  • May 11 2015

On May 5, Reps. Phil Roe, M.D. (R-TN), and Linda Sánchez (D-CA) announced that their legislation to repeal the Independent Payment Advisory Board


Weekly Washington healthcare update - May 18, 2015
  • McGuireWoods LLP
  • USA
  • May 18 2015

Health Subcommittee Advances 21st Century Cures, Full Committee Action ScheduledSenate Finance Committee Hearing: Chair Hatch to Launch New